Search research articles
Contact Us
Filters
Showing results (211-220 of 223) with videos related to
Page
of 23
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 3, 2025
Pathological response calculation assessment remains accurate with reduced tumor bed examination after neoadjuvant immunotherapy in clinically detectable stage III melanoma
R V Rawson, N G Maher, A M Menzies, et al.
Cancer Discovery
|
September 13, 2022
Comparative Genomics Provides Etiologic and Biological Insight into Melanoma Subtypes
Felicity Newell, Peter A Johansson, James S Wilmott, et al.
JAMA Dermatology
|
April 9, 2025
Global Applicability of a Risk Prediction Tool for Sentinel Node Positivity in Patients With Primary Cutaneous Melanoma
Serigne N Lo, Caroline Gjorup, Annette Hougaard Chakera, et al.
Nature Medicine
|
February 9, 2021
Survival and biomarker analyses from the OpACIN-neo and OpACIN neoadjuvant immunotherapy trials in stage III melanoma
E A Rozeman, E P Hoefsmit, I L M Reijers, et al.
Nature Communications
|
July 20, 2019
Whole-genome landscape of mucosal melanoma reveals diverse drivers and therapeutic targets
Felicity Newell, Yan Kong, James S Wilmott, et al.
The Lancet. Oncology
|
June 5, 2019
Identification of the optimal combination dosing schedule of neoadjuvant ipilimumab plus nivolumab in macroscopic stage III melanoma (OpACIN-neo): a multicentre, phase 2, randomised, controlled trial
Elisa A Rozeman, Alexander M Menzies, Alexander C J van Akkooi, et al.
The Lancet. Oncology
|
July 4, 2019
Neoadjuvant systemic therapy in melanoma: recommendations of the International Neoadjuvant Melanoma Consortium
Rodabe N Amaria, Alexander M Menzies, Elizabeth M Burton, et al.
Annals of Surgical Oncology
|
April 15, 2022
Correction to: Neoadjuvant Systemic Therapy (NAST) in Patients with Melanoma: Surgical Considerations by the International Neoadjuvant Melanoma Consortium (INMC)
Alexander C J van Akkooi, Tina J Hieken, Elizabeth M Burton, et al.
Annals of Surgical Oncology
|
January 28, 2022
Neoadjuvant Systemic Therapy (NAST) in Patients with Melanoma: Surgical Considerations by the International Neoadjuvant Melanoma Consortium (INMC)
Alexander C J van Akkooi, Tina J Hieken, Elizabeth M Burton, et al.
Nature
|
May 4, 2017
Whole-genome landscapes of major melanoma subtypes
Nicholas K Hayward, James S Wilmott, Nicola Waddell, et al.
Page
of 23
Search research articles
Search
Showing results (211-220 of 223) with videos related to
Sort By:
Page
of 23
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 3, 2025
Pathological response calculation assessment remains accurate with reduced tumor bed examination after neoadjuvant immunotherapy in clinically detectable stage III melanoma
R V Rawson, N G Maher, A M Menzies, et al.
Cancer Discovery
|
September 13, 2022
Comparative Genomics Provides Etiologic and Biological Insight into Melanoma Subtypes
Felicity Newell, Peter A Johansson, James S Wilmott, et al.
JAMA Dermatology
|
April 9, 2025
Global Applicability of a Risk Prediction Tool for Sentinel Node Positivity in Patients With Primary Cutaneous Melanoma
Serigne N Lo, Caroline Gjorup, Annette Hougaard Chakera, et al.
Nature Medicine
|
February 9, 2021
Survival and biomarker analyses from the OpACIN-neo and OpACIN neoadjuvant immunotherapy trials in stage III melanoma
E A Rozeman, E P Hoefsmit, I L M Reijers, et al.
Nature Communications
|
July 20, 2019
Whole-genome landscape of mucosal melanoma reveals diverse drivers and therapeutic targets
Felicity Newell, Yan Kong, James S Wilmott, et al.
The Lancet. Oncology
|
June 5, 2019
Identification of the optimal combination dosing schedule of neoadjuvant ipilimumab plus nivolumab in macroscopic stage III melanoma (OpACIN-neo): a multicentre, phase 2, randomised, controlled trial
Elisa A Rozeman, Alexander M Menzies, Alexander C J van Akkooi, et al.
The Lancet. Oncology
|
July 4, 2019
Neoadjuvant systemic therapy in melanoma: recommendations of the International Neoadjuvant Melanoma Consortium
Rodabe N Amaria, Alexander M Menzies, Elizabeth M Burton, et al.
Annals of Surgical Oncology
|
April 15, 2022
Correction to: Neoadjuvant Systemic Therapy (NAST) in Patients with Melanoma: Surgical Considerations by the International Neoadjuvant Melanoma Consortium (INMC)
Alexander C J van Akkooi, Tina J Hieken, Elizabeth M Burton, et al.
Annals of Surgical Oncology
|
January 28, 2022
Neoadjuvant Systemic Therapy (NAST) in Patients with Melanoma: Surgical Considerations by the International Neoadjuvant Melanoma Consortium (INMC)
Alexander C J van Akkooi, Tina J Hieken, Elizabeth M Burton, et al.
Nature
|
May 4, 2017
Whole-genome landscapes of major melanoma subtypes
Nicholas K Hayward, James S Wilmott, Nicola Waddell, et al.
Page
of 23